Skip to main content
Equibles

Michel Vounatsos

CEO

Biogen Inc. (BIIB)

Equibles does not estimate personal net worth.

Get an email with a short summary when Biogen Inc. publishes a filing, an earnings call transcript or a press release.

Get BIIB alerts

About Michel Vounatsos

Michel Vounatsos is recorded as CEO at Biogen Inc. (BIIB). The proxy statement of Biogen Inc. reports total compensation of $26,625,221 for Michel Vounatsos in fiscal 2022, including a base salary of $1,626,039. Disclosed compensation is on record for 5 fiscal years. Michel Vounatsos has spoken on 10 earnings calls across 1 company, most recently for Biogen Inc. on October 25, 2022. Biogen Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Biogen Inc. includes Christopher A. Viehbacher (CEO and Board Member), Caroline D. Dorsa (Chairman), Michael R. McDonnell (CFO) and 7 others.

Michel Vounatsos on recent calls

“In addition to key developments across our pipeline, which includes 12 programs in phase 3, we continue to execute progress, and we are pleased to be raising our full-year financial guidance.”
CEO, Biogen Inc. Q3 FY2022 Earnings Call ·
“Biogen continued to execute well in the second quarter, and we are pleased to be raising our full year financial guidance. We believe our achievements are critical steps on our path to drive renewed value creation for both patients and shareholders over time.”
CEO, Biogen Inc. Q2 FY2022 Earnings Call ·
“We continue to execute on our core business objectives in the first quarter. Mike and Priya will review our quarterly performance and recent progress in R&D, while I focus on our strategy and near-term operational priorities.”
CEO, Biogen Inc. Q1 FY2022 Earnings Call ·
“I will start by briefly reviewing our financial performance and Mike will provide more details.”
CEO, Biogen Inc. Q4 FY2021 Earnings Call ·
“We continue to view 2021 as a transformational year for our Company. We are satisfied with our 2021 pipeline accomplishments and the continued operational performance of the Company.”
CEO, Biogen Inc. Q3 FY2021 Earnings Call ·

Affiliation history

Company network

Leadership on record at Biogen Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2022 Biogen Inc. (BIIB) $1,626,039 $26,625,221
2021 Biogen Inc. (BIIB) $1,533,173 $17,689,665
2020 Biogen Inc. (BIIB) $1,488,462 $18,659,829
2019 Biogen Inc. (BIIB) $1,388,461 $18,159,858
2018 Biogen Inc. (BIIB) $1,276,923 $16,168,646

Recent activity